HK1033671A1 - Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses. - Google Patents
Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses.Info
- Publication number
- HK1033671A1 HK1033671A1 HK01104212A HK01104212A HK1033671A1 HK 1033671 A1 HK1033671 A1 HK 1033671A1 HK 01104212 A HK01104212 A HK 01104212A HK 01104212 A HK01104212 A HK 01104212A HK 1033671 A1 HK1033671 A1 HK 1033671A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- heteroaryl
- preparation
- therapeutic uses
- substituted pyrrole
- pyrrole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20549199 | 1999-07-21 | ||
JP36967899 | 1999-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1033671A1 true HK1033671A1 (en) | 2001-09-14 |
Family
ID=26515088
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02108839.6A HK1047587A1 (zh) | 1999-07-21 | 2001-06-19 | 雜芳替代的洛衍生物,其製法及治療上的用途 |
HK01104212A HK1033671A1 (en) | 1999-07-21 | 2001-06-19 | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02108839.6A HK1047587A1 (zh) | 1999-07-21 | 2001-06-19 | 雜芳替代的洛衍生物,其製法及治療上的用途 |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP1243589A1 (xx) |
KR (2) | KR100776958B1 (xx) |
CN (1) | CN1294129C (xx) |
AR (1) | AR024904A1 (xx) |
AT (1) | ATE264319T1 (xx) |
AU (1) | AU773453B2 (xx) |
BR (1) | BR0004534A (xx) |
CA (1) | CA2314373A1 (xx) |
DE (1) | DE60009804T2 (xx) |
DK (1) | DK1070711T3 (xx) |
ES (1) | ES2216826T3 (xx) |
HK (2) | HK1047587A1 (xx) |
HU (1) | HUP0002846A2 (xx) |
ID (1) | ID26611A (xx) |
IL (1) | IL137365A0 (xx) |
MX (1) | MXPA00007199A (xx) |
NO (1) | NO20003734L (xx) |
NZ (1) | NZ505924A (xx) |
PL (1) | PL341620A1 (xx) |
PT (1) | PT1070711E (xx) |
TR (1) | TR200002120A2 (xx) |
TW (1) | TWI259834B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ105499A0 (en) | 1999-06-18 | 1999-07-08 | Biota Scientific Management Pty Ltd | Antiviral agents |
US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
EP1352906A4 (en) * | 2001-01-18 | 2004-06-16 | Sankyo Co | COMPOSITIONS FOR PREVENTION OR TREATMENT OF LIVER DISEASES |
WO2002057255A1 (fr) * | 2001-01-22 | 2002-07-25 | Sankyo Company, Limited | Derives du pyrrole substitues en 4 ou 5 |
ATE377598T1 (de) | 2001-01-22 | 2007-11-15 | Sankyo Co | Durch bicyclische aminogruppen substituierte verbindungen |
EG23054A (en) * | 2001-01-22 | 2004-02-29 | Sankyo Co | Pyrrole derivatives their preparation and their therapeutic uses |
WO2002062792A1 (fr) * | 2001-02-02 | 2002-08-15 | Takeda Chemical Industries, Ltd. | Inhibiteur de jnk |
WO2002080974A1 (fr) * | 2001-04-04 | 2002-10-17 | Sankyo Company, Limited | Utilisation medicale d'inhibiteur de production de cytokine |
WO2002094267A1 (fr) * | 2001-05-24 | 2002-11-28 | Sankyo Company, Limited | Preparation pharmaceutique pour prevenir ou traiter l'arthrite |
WO2003015781A1 (fr) * | 2001-08-15 | 2003-02-27 | Sankyo Company, Limited | Nouvelles compositions pharmaceutiques antidiabetiques |
AU2003252212A1 (en) * | 2002-07-19 | 2004-02-09 | Sankyo Company, Limited | Bicyclic unsaturated tertiary amine compound |
US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
CA2850551A1 (en) * | 2011-09-30 | 2013-04-04 | Endo Pharmaceuticals Inc. | Pyridine derivatives |
WO2014007228A1 (ja) | 2012-07-03 | 2014-01-09 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
EP3886854A4 (en) | 2018-11-30 | 2022-07-06 | Nuvation Bio Inc. | PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
ATE235239T1 (de) * | 1995-08-10 | 2003-04-15 | Merck & Co Inc | 2-substituierte aryl-pyrrolen, zusammensetzungen solche verbindungen enthaltend und deren verwendung |
US5792778A (en) * | 1995-08-10 | 1998-08-11 | Merck & Co., Inc. | 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
-
2000
- 2000-07-18 IL IL13736500A patent/IL137365A0/xx unknown
- 2000-07-20 EP EP02011912A patent/EP1243589A1/en not_active Withdrawn
- 2000-07-20 AT AT00306196T patent/ATE264319T1/de not_active IP Right Cessation
- 2000-07-20 CA CA002314373A patent/CA2314373A1/en not_active Abandoned
- 2000-07-20 ES ES00306196T patent/ES2216826T3/es not_active Expired - Lifetime
- 2000-07-20 NO NO20003734A patent/NO20003734L/no not_active Application Discontinuation
- 2000-07-20 PT PT00306196T patent/PT1070711E/pt unknown
- 2000-07-20 EP EP00306196A patent/EP1070711B1/en not_active Expired - Lifetime
- 2000-07-20 DE DE60009804T patent/DE60009804T2/de not_active Expired - Fee Related
- 2000-07-20 DK DK00306196T patent/DK1070711T3/da active
- 2000-07-20 TW TW089114563A patent/TWI259834B/zh not_active IP Right Cessation
- 2000-07-21 CN CNB001313037A patent/CN1294129C/zh not_active Expired - Fee Related
- 2000-07-21 KR KR1020000042064A patent/KR100776958B1/ko not_active IP Right Cessation
- 2000-07-21 BR BR0004534-9A patent/BR0004534A/pt not_active Application Discontinuation
- 2000-07-21 HU HU0002846A patent/HUP0002846A2/hu unknown
- 2000-07-21 ID IDP20000612A patent/ID26611A/id unknown
- 2000-07-21 MX MXPA00007199A patent/MXPA00007199A/es unknown
- 2000-07-21 NZ NZ505924A patent/NZ505924A/en unknown
- 2000-07-21 AU AU48755/00A patent/AU773453B2/en not_active Ceased
- 2000-07-21 AR ARP000103779A patent/AR024904A1/es unknown
- 2000-07-21 TR TR2000/02120A patent/TR200002120A2/xx unknown
- 2000-07-21 PL PL00341620A patent/PL341620A1/xx unknown
-
2001
- 2001-06-19 HK HK02108839.6A patent/HK1047587A1/zh unknown
- 2001-06-19 HK HK01104212A patent/HK1033671A1/xx not_active IP Right Cessation
-
2007
- 2007-01-22 KR KR1020070006711A patent/KR20070026708A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL137365A0 (en) | 2001-07-24 |
EP1070711A2 (en) | 2001-01-24 |
AR024904A1 (es) | 2002-10-30 |
NZ505924A (en) | 2001-11-30 |
KR20010049843A (ko) | 2001-06-15 |
HUP0002846A2 (hu) | 2002-07-29 |
TWI259834B (en) | 2006-08-11 |
HU0002846D0 (en) | 2000-09-28 |
CA2314373A1 (en) | 2001-01-21 |
CN1294129C (zh) | 2007-01-10 |
KR100776958B1 (ko) | 2007-11-27 |
AU773453B2 (en) | 2004-05-27 |
ATE264319T1 (de) | 2004-04-15 |
EP1070711B1 (en) | 2004-04-14 |
TR200002120A3 (tr) | 2001-06-21 |
DE60009804T2 (de) | 2005-01-05 |
ES2216826T3 (es) | 2004-11-01 |
TR200002120A2 (tr) | 2001-06-21 |
DK1070711T3 (da) | 2004-05-10 |
ID26611A (id) | 2001-01-25 |
PT1070711E (pt) | 2004-06-30 |
AU4875500A (en) | 2001-02-01 |
CN1295069A (zh) | 2001-05-16 |
EP1243589A1 (en) | 2002-09-25 |
KR20070026708A (ko) | 2007-03-08 |
NO20003734D0 (no) | 2000-07-20 |
PL341620A1 (en) | 2001-01-29 |
MXPA00007199A (es) | 2003-03-12 |
EP1070711A3 (en) | 2001-01-31 |
HK1047587A1 (zh) | 2003-02-28 |
BR0004534A (pt) | 2001-02-28 |
NO20003734L (no) | 2001-01-22 |
DE60009804D1 (de) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3957600A (en) | Piperidyl-imidazole derivatives, their preparations and therapeutic uses | |
HK1048999A1 (zh) | 氮雜䓬吲衍生物,它們的製備和應用 | |
HK1061679A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use. | |
ZA200007638B (en) | Pyrazoline derivatives, their preparation and application as medicaments. | |
IL145150A0 (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
ZA200003706B (en) | Cyclobutene derivatives, their preparation and their therapeutic uses. | |
HK1033671A1 (en) | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses. | |
HUP0105039A3 (en) | Fungicidal propargylether derivatives, preparation and use thereof | |
ZA200001746B (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use. | |
ZA200204814B (en) | Substituted phenyl-piperazine derivatives, their preparation and use. | |
MXPA03000644A (es) | Nuevos derivados de indol y uso como medicamentos. | |
ZA989664B (en) | 3-substituted tetrahydropyrimidinone derivatives, their preparation and use. | |
AU3971500A (en) | Indazole derivatives, preparation and therapeutic application thereof | |
HUP0201810A3 (en) | Sootepenseone and its derivatives, their preparation and use as medicament | |
ZA200110271B (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods. | |
MXPA03006162A (es) | Derivados de mikanolida, su preparacion y sus usos terapeuticos. | |
ZA200001747B (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use. | |
ZA200109571B (en) | Novel compounds, their use and preparation. | |
AU5524400A (en) | Novel 6-amino-uracil derivatives, preparation and use thereof | |
IL149993A0 (en) | Novel heteroaryl derivatives, their preparation and use | |
ZA200003705B (en) | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses. | |
IL161859A0 (en) | 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
HUP0203557A3 (en) | Novel amidine derivatives, preparation and use thereof as medicines | |
AU2001237518A1 (en) | Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application | |
AU3971800A (en) | 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080720 |